Bliss GVS Pharma Performance
- Today's Low
- ₹436
- Today's High
- ₹450
- 52 Week Low
- ₹118
- 52 Week High
- ₹463
- Open Price₹441
- Previous Close₹437
- Volume521,869
- 50 DMA₹325.95
- 100 DMA₹275.52
- 200 DMA₹229.28
Bliss GVS Pharma Chart
Investment Returns
- Over 1 Month + 59.92%
- Over 3 Month + 109.3%
- Over 6 Month + 203.28%
- Over 1 Year + 194.99%
Smart Investing Starts Here Start SIP with Bliss GVS Pharma for Steady Growth!
Bliss GVS Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 35.9
- PEG Ratio
- 0.7
- Market Cap Cr
- 4,632
- P/B Ratio
- 3.9
- Average True Range
- 21.48
- EPS
- 12.32
- Dividend Yield
- 0.2
- MACD Signal
- 40.97
- RSI
- 71.99
- MFI
- 86.43
Latest Stock News Updates
Pharmaceuticals company Bliss GVS Pharma announced Q4FY26 & FY26 results Revenue from operations stood at Rs 25,690 lakhs in Q4FY26 compared to Rs 19,798 lakhs in Q4FY25 PBT stood at Rs 4,404 lakhs in Q4FY26 compared to Rs 2,344 lakhs in Q4FY25 Net Profit stood at Rs 3,699 lakhs in Q4FY26 compared to Rs 1,665 lakhs in Q4FY25 Revenue from operations stood at Rs 92,711 lakhs in FY26 compared to Rs 80,972 lakhs in FY25 PBT stood at Rs 18,958 lakhs in FY26 compared to Rs 12,563 lakhs in FY25 Net Profit stood at Rs 13,427 lakhs in FY26 compared to Rs 9,025 lakhs in FY25 Result PDF
- Trendlyne
- 4 weeks 2 days ago
Key Highlights Revenue from Operation Rs 30,745.88 Lakhs EBITDA Rs 5,869.56 Lakhs 19% Revenue from Operation Rs 23,284.38 Lakhs EBITDA Rs 4,498.07 Lakhs 19% Other Income Rs 1388.20 Lakhs Other Income Rs 1013.00 Lakhs PBT Rs 6381.44 Lakhs 20% PBT Rs 4,667.44 Lakh 19% PAT Rs 4,638.54 Lakhs 14% PAT Rs 3,588.33 Lakhs 15% Result PDF
- Trendlyne
- 4 years 7 months ago
Multiple promoter and promoter group entities in Bliss GVS Pharma have sold shares over the past week on the market via insider trades. This included a share sale by Promoter Director Narasimha Kamath, who sold 3.55% of total shares on the market for an average price of Rs. 152.8. The company is currently trading at Rs. 160 share price on the stock market. Also selling off Bliss shares were three other promoter group or promoter-directors. In all, 10.6% of Bliss GVS shares were disposed of in the market. FII Polus Global Fund has acquired 8.04% of the company via an SAST transaction.
- Trendlyne
- 7 years 4 months ago
Bliss GVS Pharma Financials
Bliss GVS Pharma Technicals
EMA & SMA
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹388.00
- 50 Day
- ₹326.00
- 100 Day
- ₹275.50
- 200 Day
- ₹229.30
Resistance and Support
- R3 461.00
- R2 455.45
- R1 446.65
- S1 432.30
- S2 426.75
- S3 417.95
Bliss GVS Pharma Corporate Actions - Bonus, Splits, Dividends
About Bliss GVS Pharma
- NSE Symbol
- BLISSGVS
- BSE Symbol
- 506197
- Managing Director
- Mr. Gagan Harsh Sharma
- ISIN
- INE416D01022
Similar Stocks to Bliss GVS Pharma
Popular Stocks
Bliss GVS Pharma FAQs
Bliss GVS Pharma share price is ₹437 As on 13 June, 2026 | 08:44
The Market Cap of Bliss GVS Pharma is ₹4632 Cr As on 13 June, 2026 | 08:44
The P/E ratio of Bliss GVS Pharma is 35.9 As on 13 June, 2026 | 08:44
The PB ratio of Bliss GVS Pharma is 3.9 As on 13 June, 2026 | 08:44
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.